Articular manifestations of human immunodeficiency virus infection

Best Practice and Research: Clinical Rheumatology

Volumn 17, Issue 2, 2003, Pages 265-287

  Mody, Girish M ^a   Parke, Frank A ^b   Reveille, John D ^b  

^a UNIVERSITY OF KWAZULU NATAL   (South Africa)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

Arthritis; Avascular necrosis; HAART; HIV; Reactive arthritis; Septic arthritis

Indexed keywords

ANALGESIC AGENT; ANTIRETROVIRUS AGENT; ANTIVIRUS AGENT; BROMOCRIPTINE; CORTICOSTEROID; ETANERCEPT; ETRETINATE; GOLD; HYDROXYCHLOROQUINE; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; PROTEINASE INHIBITOR; SALAZOSULFAPYRIDINE; TUMOR NECROSIS FACTOR ANTIBODY; ZIDOVUDINE; ANTINUCLEAR ANTIBODY; HLA B27 ANTIGEN; RHEUMATOID FACTOR;

AFRICA; ARTHRALGIA; ARTHRITIS; ARTHROPATHY; AVASCULAR NECROSIS; BACTERIAL ARTHRITIS; BONE DISEASE; CAUCASIAN; CLINICAL FEATURE; CLINICAL TRIAL; DEVELOPING COUNTRY; DISEASE ASSOCIATION; DISEASE COURSE; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DOSE RESPONSE; DRUG DEPENDENCE; EUROPE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERLIPIDEMIA; INFECTION; INSULIN RESISTANCE; LIPODYSTROPHY; LONGITUDINAL STUDY; METABOLIC DISORDER; NONHUMAN; NORTH AMERICA; OSTEOPOROSIS; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSORIATIC ARTHRITIS; REACTIVE ARTHRITIS; REVIEW; RHEUMATOID ARTHRITIS; RISK FACTOR; SOUTH AMERICA; SOUTHEAST ASIA; SPONDYLOARTHROPATHY; VIRUS PATHOGENESIS; ACQUIRED IMMUNE DEFICIENCY SYNDROME; DISEASE EXACERBATION; DRUG INHIBITION; INFECTION RISK; SYSTEMIC LUPUS ERYTHEMATOSUS; VIRUS LOAD; VIRUS REPLICATION;

EID: 0038381407     PISSN: 15216942     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1521-6942(03)00003-2     Document Type: Review

References (83)

1. Winchester R, Bernstein DH, Fischer HD et al. The co-occurrence of Reiter's syndrome and acquired immunodeficiency. Annals of Internal Medicine 1987; 106: 19-26.
2. Solinger AM & Hess EV. Rheumatic diseases and AIDS - Is the association real? Journal of Rheumatology 1993; 20: 678-683.
3. Hochberg MC, Fox R, Nelson KE & Saah A. HIV infection is not associated with Reiter's syndrome: Data from the Johns Hopkins Multicenter AIDS Cohort Study. AIDS 1990; 4: 1149-1151.
4. Clark M, Kinsolvinc M & Chernoff D. The prevalence of arthritis in two HIV infected cohorts. Arthritis and Rheumatism 1989; 32: 585.
5. Clark MR, Solinger AM & Hochberg MC. Human immunodeficiency virus infection is not associated with Reiter's syndrome. Data from three large cohort studies. Rheumatic Disease Clinics of North America 1992; 18: 267-276.
6. Berman A, Reboredo G, Spindler A et al. Rheumatic manifestations in populations at risk for HIV infection: The added effect of HIV. Journal of Rheumatology 1991; 18: 1564-1567.
7. Medina-Rodriguez F, Guzman C, Jara LJ et al. Rheumatic manifestations in human immunodeficiency virus positive and negative individuals: A study of 2 populations with similar risk factors. Journal of Rheumatology 1993; 20: 1880-1884.
8. Buskila D, Gladdman DD, Langevitz P et al. Rheumatologic manifestations of infection with the human immunodeficiency virus (HIV). Clinical and Experimental Rheumatology 1990; 8: 567-573.
9. Calabrese LH, Kelley DM, Myers A et al. Rheumatic symptoms and human immunodeficiency virus infection. The influence of clinical and laboratory variables in a longitudinal cohort study. Arthritis and Rheumatism 1991; 34: 257-263.
10. Cuellar ML. HIV infection-associated inflammatory musculoskeletal disorders. Rheumatic Disease Clinics of North America 1998; 24: 403-421.
11. Crawford TB, Adams DS, Sande RD et al. The connective tissue component of the caprine arthritis-encephalitis syndrome. American Journal of Pathology 1980; 100: 443-454.
12. Michaels FH, Banks KL & Reitz Jr MS. Lessons from caprine and ovine retrovirus infections. Rheumatic Disease Clinics of North America 1991; 17: 5-23.
13. Nishioka K, Nakajima T, Hasunuma T & Sato K. Rheumatic manifestation of human leukemia virus infection. Rheumatic Disease Clinics of North America 1993; 19: 489-503.
14. Rynes RI, Goldenberg DL, DiGiacomo R et al. Acquired immunodeficiency syndrome-associated arthritis. American Journal of Medicine 1988; 84: 810-816.
15. Bentin J, Feremans W, Pasteels IL et al. Chronic acquired immunodeficiency syndrome-associated arthritis: A synovial ultrastructural study. Arthritis and Rheumatism 1990; 33: 268-273.
16. Dalton ADA, Harcourt-Webater JN & Keat ACS. Synovium in AIDS: A postmortem study. British Medical Journal 1990; 300: 1239-1240.
17. Withrington RH, Cornes P, Harris JR et al. Isolation of human immunodeficiency virus from synovial fluid of a patient with reactive arthritis. British Medical Journal 1987; 294: 484.
18. Espinoza LR, Aguilar JL, Espinoza CG et al. HIV associated arthropathy: HIV antigen demonstration in the synovial membrane. Journal of Rheumatology 1990; 17: 1195-1201.
19. Hughes RA, Macatonia SE, Rowe IF et al. The detection of human immunodeficiency virus DNA in dendritic cells from the joints of patients with aseptic arthritis. British Journal of Rheumatology 1990; 29: 166-170.
20. Berman A, Espinoza JR, Diaz JD et al. Rheumatic manifestations of human immunodeficiency virus infection. American Journal of Medicine 1988; 85: 59-64.
21. Munoz-Fernandez S, Cardenal A, Balsa A et al. Rheumatic manifestations in 556 patients with human immunodeficiency virus infection. Seminars in Arthritis and Rheumatism 1991; 21: 30-39.
22. Rowe IF, Forster SM, Seifert MH et al. Rheumatological lesions in individuals with human immunodeficiency virus infection. Quarterly Journal of Medicine 1989; 73: 1167-1184.
23. Casado E, Olive A, Holgado S et al. Musculoskeletal manifestations in patients positive for human immunodeficiency virus: Correlation with CD4 count. Journal of Rheumatology 2001; 28: 802-804.
24. Johnson RW, Williams FM, Kazi S et al. HIV-associated polymyositis: A longitudinal study of outcome. Arthritis and Rheumatism 2003, in press.
25. Davis P, Stein M, Latif A & Emmanuel J. Acute arthritis in Zimbabwean patients: Possible relationship to human immunodeficiency virus infection. Journal of Rheumatology 1989; 16: 346-348.
26. Njobvu P, McGill P, Kerr H et al. Spondyloarthropathy and human immunodeficiency virus infection in Zambia. Journal of Rheumatology 1998; 25: 1553-1559.
27. Stein CM & Davis P. Arthritis associated with HIV infection in Zimbabwe. Journal of Rheumatology 1996; 23: 506-511.
28. Blanche P, Taelman H, Saraux A et al. Acute arthritis and human immunodeficiency virus infection in Rwanda. Journal of Rheumatology 1993; 20: 2123-2127.
29. Bileckot R, Mouaya A & Makuva M. Prevalence and clinical presentations of arthritis in HIV positive patients seen at a rheumatology department in Congo - Brazzaville. Revue Rheumatisme 1997; 14: 60-63.
30. Louthrenoo W. Musculoskeletal manifestations in HIV infection in Thailand. An analysis of 100 cases. Journal of Clinical Rheumatology 1997; 3: 258-268.
31. Lutalo SK. Chronic inflammatory rheumatic diseases in black Zimbabweans. Annals of the Rheumatic Diseases 1985; 44: 121-125.
32. Du Toit ED, Emmanuel JC, West G et al. HLA frequencies in black Zimbabweans. Tissue Antigens 1990; 36: 122-124.
33. Blanche P, Sicard D, Saraux A & Taelman H. Arthritis and HIV infection in Kigali, Rwanda, and Paris, France. Journal of Rheumatology 1997; 24: 1449-1450.
34. Mijiyawa M. Spondyloarthropathies in patients attending the rheumatology unit of Lome Hospital. Journal of Rheumatology 1993; 20: 1167-1169.
35. Jellis JE. Orthopaedic surgery and HIV disease in Africa. International Orthopaedics 1996; 20: 253-256.
36. Njobvu P & McGill P. Psoriatic arthritis and human immunodeficiency virus infection in Zambia. Journal of Rheumatology 2000; 27: 1699-1702.
37. Pouchot J, Simonpoli AM, Bortolotti V et al. Painful articular syndrome and human immunodeficiency virus infection. Archives of Internal Medicine 1992; 152: 646-649.
38. Reveille JD, Conant MA & Duvic M. HIV-associated psoriasis, psoriatic arthritis and Reiter's syndrome. A disease continuum? Arthritis and Rheumatism 1990; 33: 1574-1578.
39. Johnson TM, Duvic M, Rapini RP & Rios A. AIDS exacerbates psoriasis. New England Journal of Medicine 1985; 313: 1415.
40. Duvic M, Johnson TM, Rapini RP et al. Acquired immunodeficiency syndrome-associated psoriasis and Reiter's syndrome. Archives of Dermatology 1987; 123: 1622-1632.
41. Berman A, Cahn P, Perez H et al. Human immunodeficiency virus infection associated arthritis: Clinical characteristics. Journal of Rheumatology 1999; 26: 1158-1162.
42. Reveille JD. The changing spectrum of rheumatic disease in human immunodeficiency virus infection. Seminars in Arthritis and Rheumatism 2000; 30: 147-166.
43. Goldenberg DL. Septic arthritis and other infections of rheumatological significance. Rheumatic Disease Clinics of North America 1991; 17: 149-156.
44. Espinoza LR & Berman A. Soft tissues and osteo-articular infections in HIV-infected patients and other immunodeficient states. Baillière's Clinical Rheumatology 1999; 13: 115-128.
45. Saraux A, Taelman H, Blanche P et al. HIV infection as a risk factor for septic arthritis. British Journal of Rheumatology 1997; 36: 333-337.
46. Munoz-Fernandez S, Quiralte J, Del Arco A et al. Osteoarticular infection associated with the human immunodeficiency virus. Clinical and Experimental Rheumatology 1991; 9: 489-493.
47. Ventura G, Gasparini G, Lucia MB et al. Osteoarticular bacterial infections are rare in HIV-infected patients. 14 cases found among 4,023 HIV-infected patients. Acta Orthopaedica Scandinavica 1997; 68: 554-558.
48. Rivera J, Monteaguda I, Lope-Longo J & Sanchez Atrio A. Septic arthritis in patients with acquired immunodeficiency syndrome with human immunodeficiency virus infection. Journal of Rheumatology 1992; 19: 1960-1962.
49. Vassilopoulos D, Chalasani P, Jurado RL et al. Musculoskeletal infections in patients with human immunodeficiency virus infection. Medicine 1997; 76: 284-294.
50. Hughes RA, Rowe IP, Shanson D & Keat ACS. Septic bone, joint and muscle lesions associated with human immunodeficiency virus infection. British Journal of Rheumatology 1992; 31: 381-388.
51. Hirsch R, Miller SM, Kazi S et al. HIV-associated atypical mycobacterial skeletal infections: A report of six cases and review of the literature. Seminars in Arthritis and Rheumatism 1996; 25: 347-356.
52. Vinetz JM & Rickman LS. Chronic arthritis due to Mycobacterium avium complex infection in a patient with the acquired immunodeficiency syndrome. Arthritis and Rheumatism 1991; 34: 1339-1340.
53. Mostaza JM, Barbado PJ, Fernandez-Martin J et al. Cutaneoarticular mucormycosis due to Cunninghamella bertholletiae in a patient with AIDS. Reviews in Infectious Diseases 1989; 11: 316.
54. Belmonte MA, Garcia-Portales R, Domenech I et al. Avascular necrosis of bone in human immunodeficiency virus infection and antiphospholipid antibodies. Journal of Rheumatology 1993; 20: 1425-1428.
55. Scribner AN, Troia-Cancio PV, Cox BA et al. Osteonecrosis in HIV: A case-control study. Journal of Acquired Immunodeficiency Syndrome and Human Retrovirology 2000; 25: 19-25.
56. Rademaker J, Dobro JS & Solomon G. Osteonecrosis and human immunodeficiency virus infections. Journal of Rheumatology 1997; 24: 601-604.
57. Olive A, Queralt C, Sirera G et al. Osteonecrosis and HIV infection: 4 more cases. Journal of Rheumatology 1998; 25: 1243-1244.
58. Calza L, Manfredi R, Mastroianni A & Chiodo F. Osteonecrosis and highly active antiretroviral therapy during HIV infection: Report of a series and literature review. AIDS Patient Care and STDs 2001; 15: 385-389.
59. Ries MD, Barcohana B, Davidson A et al. Association between human immunodeficiency virus and osteonecrosis of the femoral head. Journal of Arthroplasty 2002; 17: 135-139.
60. Molina JF, Citera G, Rosler D et al. Coexistence of human immunodeficiency virus infection and systemic lupus erythematosus. Journal of Rheumatology 1995; 22: 347-350.
61. Glesby MJ, Hoover DR & Vaamonde CM. Osteonecrosis in patients infected with human immunodeficiency virus: A case-control study. Journal of Infectious Diseases 2001; 184: 519-523.
62. Blacksin MF, Kloser PC & Simon J. Avascular necrosis of bone in human immunodeficiency virus infected patients. Clinical Imaging 1999; 23: 314-318.
63. Herman JS & Easterbrook PJ. The metabolic toxicities of antiretroviral therapy. International Journal of STD and AIDS 2001; 12: 555-562.
64. Nodak SP, Fluhme D, Kumar P et al. A vascular necrosis and protease inhibitor exposure. American Society of Microbiology 1999; 506.
65. Bonfanti P, Grabbuti A, Carradori S et al. Osteonecrosis in protease inhibitor-treated patients. Orthopedics 2001; 24: 271-272.
66. Monier P, McKown K & Bronze MS. Osteonecrosis complicating highly active antiretroviral therapy in patients infected with human immunodeficiency virus. Clinics in Infectious Diseases 2000; 31: 1488-1492.
67. Gaughan DM, Mofenson LM, Hughes MD et al. Osteonecrosis of the hip (Legg-Calve-Perthes disease) in human immunodeficiency virus-infected children. Pediatrics 2002; 109: 74.
68. Itescu S & Winchester R. Diffuse infiltrative lymphocytosis syndrome: A disorder occurring in human immunodeficiency virus-1 infection that may present as a sicca syndrome. Rheumatic Diseases Clinics of North America 1992; 18: 683-697.
69. Craven DE, Duncan RA, Stram JR et al. Response of lymphoepithelial parotid cysts to antiretroviral treatment in HIV-infected adults. Annals of Internal Medicine 1998; 128: 455-459.
70. Duvic M, Crane MM, Conant M et al. Zidovudine improves psoriasis in human immunodeficiency virus-positive males. Archives of Dermatology 1994; 130: 447-451.
71. McGonagle D, Reade S, Marzo-Ortega H et al. Human immunodeficiency virus associated spondyloarthropathy: Pathogenic insights based on imaging findings and response to highly active antiretroviral treatment. Annals of the Rheumatic Diseases 2001; 60: 696-698.
72. Ornstein MH & Sperber K. The anti-inflammatory and antiviral effects of hydroxychloroquine in two patients with acquired immunodeficiency syndrome and active inflammatory arthritis. Arthritis and Rheumatism 1996; 39: 157-161.
73. Sperber K, Talb TH, Stecher VJ et al. Inhibition of immunodeficiency virus type I replication by hydroxychloroquine in T cells and monocytes. AIDS Research and Human Retrovirology 1993; 9: 91-98.
74. Amor B. Reply to Jaffe IA: Rheumatoid arthritis and AIDS (letter). Journal of Rheumatology 1989; 16: 1345.
75. Calabrese LH, Wilke WS, Perkins AD & Tubbs RR. Rheumatoid arthritis complicated by infection with the human immunodeficiency virus and the development of Sjögren's syndrome. Arthritis and Rheumatism 1989; 32: 1453-1457.
76. Maurer TA, Zackheim HS, Tuffanelli L & Berger TG. The use of methotrexate for treatment of psoriasis in patients with HIV infection. Journal of the American Academy of Dermatology 1994; 31: 372-375.
77. Youssef PP, Bertouch JV & Jones PD. Successful treatment of human immunodeficiency virus-associated Reiter's syndrome with sulphasalazine. Arthritis and Rheumatism 1993; 36: 726.
78. Comer SS & Jasin HE. In vitro immunodeficiency effects of sulphasalazine and it's metabolites. Journal of Rheumatology 1988; 15: 580-586.
79. Carlin G, Djursater R & Smedegard G. Sulfasalazine inhibition of human granulocyte activation by inhibition of second messenger compounds. Annals of the Rheumatic Diseases 1992; 51: 1230-1236.
80. Shapiro DL & Masci JR. Treatment of HIV associated psoriatic arthritis with oral gold. Journal of Rheumatology 1996; 23: 1818-1820.
81. Louthrenoo W. Successful treatment of reactive arthritis associated with human immunodeficiency virus infection with etretinate. Report of 2 cases. Journal of Rheumatology 1993; 20: 1243-1246.
82. Medina-Rodriguez F, Jara J, Miranda JM et al. Sulfasalazine treatment of Reiter's syndrome patients may not be sufficient: Comment on the article by Youssef et al. Arthritis and Rheumatism 1992; 35: 723-726.
83. Aboulafia DM, Bundow D, Wilske K & Ochs UI. Etanercept for the treatment of human immunodeficiency virus-associated psoriatic arthritis. Mayo Clinic Proceedings 2000; 75: 1093-1098.